Research graph
References from Targeting Problems and Adhering to Standards: A Pathway to Uniform Clinical Laboratory Processes that Maximize the Benefits of Pharmacogenomics. Local targets link to admitted publications; unresolved targets remain external evidence.
Navigating pharmacogenomic testing in practice: who to test and when to test
10.1002/cpt.3704 · 2025 · External reference
Pharmacogenomic testing: strategies and technical considerations for clinical laboratories
10.5858/arpa.2025-0179-cp · 2026 · External reference
Clinical pharmacogenomic testing and reporting: a technical standard of the American College of Medical Genetics and Genomics (ACMG)
10.1016/j.gim.2021.12.009 · 2022 · External reference
Standardization can accelerate the adoption of pharmacogenomics: current status and the path forward
10.2217/pgs-2018-0028 · 2018 · External reference
Considerations when applying pharmacogenomics to your practice
10.1016/j.mayocp.2020.03.011 · 2021 · External reference
Unresolved reference
2017 · External reference
Unresolved reference
External reference
Pharmacogenomics implementation: considerations for selecting a reference laboratory
10.1002/phar.1985 · 2017 · External reference
Pharmacogenomic testing in the clinical laboratory: historical progress and future opportunities
10.3343/alm.2024.0652 · 2025 · External reference
Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: experiences from the NHLBI TOPMed program
10.1016/j.xgen.2022.100155 · 2022 · External reference
